SI-BONE, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2024, on February 24, 2025. The company reported record worldwide revenue of $49.0 million for Q4 2024, a 26% increase from the prior year period, with U.S. revenue growing 28% to $46.9 million.
A significant financial milestone was achieved with positive adjusted EBITDA of $1.9 million in Q4 2024, a substantial improvement from a $4.8 million loss in Q4 2023. For the full year 2024, worldwide revenue reached $167.2 million, up 20% from 2023, and the adjusted EBITDA loss improved by 71% to $5.1 million.
Looking ahead, SI-BONE issued 2025 worldwide revenue guidance in the range of $193.5 million to $195.5 million, implying year-over-year growth of 16% to 17%. The company anticipates achieving positive adjusted EBITDA for both the second half and the full year 2025, alongside a gross margin between 77% and 78%.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.